Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda
Loading...
Date
2020-05-05
Journal Title
Journal ISSN
Volume Title
Publisher
Clinical Infectious Diseases
Abstract
Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of “Treat All” in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/µL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.
Description
Keywords
Citation
Esther Nasuuna, Mark W Tenforde, Alex Muganzi, Joseph N Jarvis, Yukari C Manabe, Joanita Kigozi, Reduction in Baseline CD4 Count Testing Following Human Immunodeficiency Virus “Treat All” Adoption in Uganda, Clinical Infectious Diseases, Volume 71, Issue 9, 1 November 2020, Pages 2497–2499, https://doi.org/10.1093/cid/ciaa261